Newsroom

Amgen presents abstract validating use of AI and advanced data sources for asthma at CHEST

Publications

Using artificial intelligence applied to the entire patient record resulted in a 56% absolute increase and 165% relative increase in accuracy in identifying patients with severe asthma compared to a traditional, structured data-only approach. This high-validity approach was also able to identify disease subtypes such as eosinophilic asthma. Differences in accuracy between the two approaches were particularly pronounced for symptoms, findings, and procedures, with a 54% – 99% absolute increase and 131% – 2162% relative increase in accuracy for the high-validity approach.

Read at the original outlet
All news
Get started

Ready to advance your evidence program?

Speak with our team about how the Verantos pharmacoepidemiology stack can accelerate your timeline.